Gal Dinstag

Tel Aviv, TA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

SYNTHESIS-Breast: A prospective early-phase trial of a genetic-interaction- focused computational algorithm in advanced metastatic breast cancer.

SYNTHESIS-Breast: A prospective early-phase trial of a genetic-interaction- focused computational algorithm in advanced metastatic breast cancer.

Journal: Research square

Published: June 05, 2026

Prediction of clinical outcomes of advanced cutaneous squamous cell carcinoma to PD-1 inhibition directly from histopathology slides using inferred transcriptomics.

Prediction of clinical outcomes of advanced cutaneous squamous cell carcinoma to PD-1 inhibition directly from histopathology slides using inferred transcriptomics.

Journal: Frontiers in immunology

Published: March 03, 2026

Longitudinal validation of ENLIGHT, an AI predictor of immunotherapy response and resistance, in pan-cancer cohorts.

Longitudinal validation of ENLIGHT, an AI predictor of immunotherapy response and resistance, in pan-cancer cohorts.

Journal: NPJ precision oncology

Published: January 26, 2026

Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slides using inferred transcriptomics.

Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slides using inferred transcriptomics.

Journal: Journal for immunotherapy of cancer

Published: November 30, 2024

Prediction of clinical outcomes of immune checkpoint inhibitors in advanced head and neck cancer directly from histopathology slides using inferred transcriptomics.

Prediction of clinical outcomes of immune checkpoint inhibitors in advanced head and neck cancer directly from histopathology slides using inferred transcriptomics.

Journal: Oral oncology

Published: October 20, 2024

Prediction of cancer treatment response from histopathology images through imputed transcriptomics.

Prediction of cancer treatment response from histopathology images through imputed transcriptomics.

Journal: Research square

Published: October 04, 2023

A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics.

A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics.

Journal: Nature cancer

Published: August 10, 2023

Fibrolamellar carcinoma transcriptomic-based treatment prediction: complete response after nivolumab and ipilimumab.

Fibrolamellar carcinoma transcriptomic-based treatment prediction: complete response after nivolumab and ipilimumab.

Journal: Journal for immunotherapy of cancer

Published: November 14, 2022

Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical Setting.

Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical Setting.

Journal: Cancer discovery

Published: April 19, 2022

Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome.

Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome.

Journal: Med (New York, N.Y.)

Published: April 11, 2022

Synthetic lethality-mediated precision oncology via the tumor transcriptome.

Synthetic lethality-mediated precision oncology via the tumor transcriptome.

Journal: Cell

Published: April 14, 2020

PRODIGY: personalized prioritization of driver genes.

PRODIGY: personalized prioritization of driver genes.

Journal: Bioinformatics (Oxford, England)

Published: June 11, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026